OrthoPediatrics commenced limited U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (EOS). This represents the company’s 80th system designed to treat musculoskeletal issues in children.
The system is made possible with the Shilla technology licensed from Medtronic.
VerteGlide represents the second in a series of technologies OrthoPediatrics is developing to address the challenges of this special group of children suffering from debilitating and life-threatening consequences of EOS. With its unique design, the VerteGlide Spinal Growth Guidance System is designed to allow for deformity correction and minimize repeat surgeries needed until skeletal maturity.
OrthoPediatrics commenced limited U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (EOS). This represents the company’s 80th system designed to treat musculoskeletal issues in children.
The system is made possible with the Shilla technology licensed from Medtronic.
VerteGlide represents...
OrthoPediatrics commenced limited U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (EOS). This represents the company’s 80th system designed to treat musculoskeletal issues in children.
The system is made possible with the Shilla technology licensed from Medtronic.
VerteGlide represents the second in a series of technologies OrthoPediatrics is developing to address the challenges of this special group of children suffering from debilitating and life-threatening consequences of EOS. With its unique design, the VerteGlide Spinal Growth Guidance System is designed to allow for deformity correction and minimize repeat surgeries needed until skeletal maturity.
Copy to clipboard 
